Literature DB >> 17344888

Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response.

S A Rempel1, R C Hawley, J A Gutiérrez, E Mouzon, K R Bobbitt, N Lemke, C R Schultz, L R Schultz, W Golembieski, J Koblinski, S VanOsdol, C G Miller.   

Abstract

Sparc-null mice have been used as models to assess tumor-host immune cell interactions. However, it is not known if they have a competent immune system. In this study, the immune systems of Sparc wild-type and null mice were compared. Mice were assessed for differences in total body weight, spleen weight and spleen-to-body weight ratios. Spleens were compared with respect to morphology, and Sparc, Ki-67, MOMA-1 and IgM expression. Immune cells in blood, bone marrow and spleen were assessed by blood smears, automated blood panel, and flow cytometry. Additionally, the ability of Sparc-null mice to respond to immune challenge was evaluated using a footpad model. The morphological and immunohistochemical results indicated that Sparc-null spleens had more white pulp, hyperproliferative B cells in the germinal centers, and decreased marginal zones. Sparc-null spleens lacked normal Sparc expression in red and white pulp, marginal zones, endothelial and sinusoidal cells. By flow analysis, B cells were decreased and T cells were increased in the bone marrow. Finally, Sparc-null mice were unable to mount an immune response following footpad lipopolysaccharide challenge. These data confirm that Sparc-null mice have an impaired immune system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344888     DOI: 10.1038/sj.gene.6364388

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  17 in total

1.  Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarization.

Authors:  Hiroe Toba; Lisandra E de Castro Brás; Catalin F Baicu; Michael R Zile; Merry L Lindsey; Amy D Bradshaw
Journal:  Am J Physiol Cell Physiol       Date:  2015-04-15       Impact factor: 4.249

2.  LPS induces greater bone and PDL loss in SPARC-null mice.

Authors:  J Trombetta-Esilva; H Yu; D N Arias; C Rossa; K L Kirkwood; A D Bradshaw
Journal:  J Dent Res       Date:  2010-12-29       Impact factor: 6.116

Review 3.  The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.

Authors:  Sharon L I Wong; Maria B Sukkar
Journal:  Br J Pharmacol       Date:  2016-11-25       Impact factor: 8.739

Review 4.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

Review 5.  Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC).

Authors:  Sarah McCurdy; Catalin F Baicu; Stephane Heymans; Amy D Bradshaw
Journal:  J Mol Cell Cardiol       Date:  2009-07-03       Impact factor: 5.000

6.  Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice.

Authors:  Luciene Machado do Reis; Catherine B Kessler; Douglas J Adams; Joseph Lorenzo; Vanda Jorgetti; Anne M Delany
Journal:  Bone       Date:  2008-04-13       Impact factor: 4.398

Review 7.  The Influence of the Extracellular Matrix in Inflammation: Findings from the SPARC-Null Mouse.

Authors:  Hannah J Riley; Amy D Bradshaw
Journal:  Anat Rec (Hoboken)       Date:  2019-04-24       Impact factor: 2.227

8.  Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling.

Authors:  Anne M Delany; Kurt David Hankenson
Journal:  J Cell Commun Signal       Date:  2009-10-28       Impact factor: 5.782

9.  Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers.

Authors:  Hee-Sung Ahn; Jung Yoon Ho; Jiyoung Yu; Jeonghun Yeom; Sanha Lee; Soo Young Hur; Yuyeon Jung; Kyunggon Kim; Youn Jin Choi
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

10.  Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice.

Authors:  Catalina Atorrasagasti; Estanislao Peixoto; Jorge B Aquino; Néstor Kippes; Mariana Malvicini; Laura Alaniz; Mariana Garcia; Flavia Piccioni; Esteban J Fiore; Juan Bayo; Ramón Bataller; Elizabeth Guruceaga; Fernando Corrales; Osvaldo Podhajcer; Guillermo Mazzolini
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.